Adam Levy
Förmögenhet: 55 437 $ per 2026-09-30
Förmögenhet: 55 437 $ per 2026-09-30
Mr. Adam S.
Levy is a Chief Financial Officer at Mineralys Therapeutics, Inc. He is on the Board of Directors at Praxis Bioresearch LLC.
Mr. Levy was previously employed as a Chief Business Officer by Vical, Inc., a Chief Business Officer by Brickell Subsidiary, Inc., a Chief Business Officer by Fresh Tracks Therapeutics, Inc., a Chief Business Officer by Miragen Therapeutics, Inc., a Senior Vice President by Merrill Lynch, Pierce, Fenner & Smith, Inc., a Vice President-Healthcare Investment Banking by Wedbush Securities, Inc., and a Chief Financial Officer by Sanifit Therapeutics SA. He received his undergraduate degree from Cornell University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-25 | 2 206 ( 0 % ) | 55 437 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Finansdirektör/CFO | 2022-03-01 |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Direktör/Styrelseledamot | 2023-09-19 |
| Företag | Position | Slut |
|---|---|---|
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Finansdirektör/CFO | 2022-01-01 |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Företagsledare/Principal | 2020-01-01 |
| VIRIDIAN THERAPEUTICS, INC. | Investor Relations Kontakt | - |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Företagsledare/Principal | 2016-05-01 |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Företagsledare/Principal | 2011-04-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Wedbush Securities, Inc.
Wedbush Securities, Inc. Investment Banks/BrokersFinance Provides financial services | Finance |
Brickell Subsidiary, Inc.
Brickell Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products | Health Technology |
Fresh Tracks Therapeutics, Inc.
Fresh Tracks Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops and manufactures prescription therapeutics products for treatment of autoimmune, inflammatory and debilitating diseases | Health Technology |
Praxis Bioresearch LLC
Praxis Bioresearch LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel prodrug stimulants for treatment of chronic neuropsychiatric and neurodegenerative disorders | Health Technology |
Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån